This is the authors' abstract. We don't add key points for this paper.
We report the enantioselective construction of all-carbon quaternary stereocenters (up to 99% ee) by the cationic Rh(I)/Segphos-catalyzed hydroalkenylative cyclization of 1,6-enynes with α-substituted acrylamides. This Rh catalysis proceeds with small excesses of alkenes at room temperature in most substrates to yield the desired cyclization products in high yields and enantioselectivity. Mechanistic studies indicate acrylamide-substituted C–H bond activation processes: for α-substituted acrylamides, the C–H bond is cleaved by a cationic Rh(III) complex (rhodacyclopentene); in contrast, for β-substituted acrylamides, the C–H bond is cleaved by a cationic Rh(I) complex.
No takes yet. Share an insight, caveat, or question.
Emi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: